Jump to main content
Jump to site search

Issue 39, 2016
Previous Article Next Article

Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines

Author affiliations

Abstract

A new class of tricyclic heterocycles 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines was synthesized through a Knoevenagel condensation/azide–alkyne cycloaddition reaction cascade in one-pot operation. These eight membered ring containing heterocycles exhibited moderately high anticancer activity against four cancer cell lines; human cervix cancer cell line (HeLa), human prostate cancer cell line (DU145), human breast cancer cell line (MCF-7) and human breast adenocarcinoma epithelial cell line (MDA-MB-231). Our results indicate that these compounds have a weak cytotoxic effect on normal human mammary epithelial cell line (MCF-10A). Cell cycle and apoptosis assay indicate that they inhibit the cell cycle at the G2/M phase and induce apoptosis. Through the RED100 assay, it is evident that they have potential to inhibit pBR 322 plasmid DNA cleavage by BamH1. UV-visible, fluorescence titration and viscosity studies suggested that these compounds possess DNA binding affinity.

Graphical abstract: Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 May 2016, accepted on 05 Sep 2016 and first published on 05 Sep 2016


Article type: Paper
DOI: 10.1039/C6OB01077F
Org. Biomol. Chem., 2016,14, 9294-9305

  •   Request permissions

    Synthesis, DNA binding affinity and anticancer activity of novel 4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocines

    K. N. V. Sastry, S. R. Routhu, S. G. Datta, N. Nagesh, B. N. Babu, J. B. Nanubolu, C. G. Kumar, R. A. Maurya and A. Kamal, Org. Biomol. Chem., 2016, 14, 9294
    DOI: 10.1039/C6OB01077F

Search articles by author

Spotlight

Advertisements